Abstract
MicroRNAs (miRNAs), the endogenous noncoding RNAs, are involved in carcinogenesis. Laryngeal squamous cell carcinoma (LSCC) is the common cancer in head and neck. Whether miRNAs can be used in the diagnosis of LSCC is largely unknown. The purpose of this study was to identify whether miRNAs could be use as potential biomarkers for LSCC diagnosis. The expression levels of miR-21, miR-106b and miR-375, in LSCC tissues and paired nontumor tissues were first quantitatively analyzed by reverse transcription-polymerase chain reaction. Then, the relationships between their expression levels and clinicopathological parameters of patients with LSCC were further determined. We found that these miRNAs’ expression levels were significantly different between LSCC tissues and adjacent normal tissues. Two miRNAs, miR-21 and miR-106b were found up-regulated in cancer tissues (P=0.0012 and P<0.001, respectively), while miR-375 down-regulated (P<0.001). Moreover, miR-21 and miR-106b levels were found significantly increased in poorly (G3)/moderately differentiated (G2) cancer tissues comparing with well differentiated (G1) and dysplasia (D) tissues (P<0.001, respectively). Their levels were also positively associated with lymph node metastasis (P<0.05) and TNM stages (P<0.01). However, miR-375 expression level was only found negatively associated with TNM stages. Our preliminary data suggest that three miRNAs, miR-21, miR-106b and miR- 375 might become novel tumor markers for LSCC diagnosis.
Keywords: Laryngeal squamous cell carcinoma, MicroRNAs, MiR-21, MiR-106b, MiR-375, tumor markers.
Current Pharmaceutical Biotechnology
Title:miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma
Volume: 15 Issue: 5
Author(s): Xing Yu, Yibo Wu, Yang Liu, Hongxia Deng, Zhisen Shen, Bingxiu Xiao and Junming Guo
Affiliation:
Keywords: Laryngeal squamous cell carcinoma, MicroRNAs, MiR-21, MiR-106b, MiR-375, tumor markers.
Abstract: MicroRNAs (miRNAs), the endogenous noncoding RNAs, are involved in carcinogenesis. Laryngeal squamous cell carcinoma (LSCC) is the common cancer in head and neck. Whether miRNAs can be used in the diagnosis of LSCC is largely unknown. The purpose of this study was to identify whether miRNAs could be use as potential biomarkers for LSCC diagnosis. The expression levels of miR-21, miR-106b and miR-375, in LSCC tissues and paired nontumor tissues were first quantitatively analyzed by reverse transcription-polymerase chain reaction. Then, the relationships between their expression levels and clinicopathological parameters of patients with LSCC were further determined. We found that these miRNAs’ expression levels were significantly different between LSCC tissues and adjacent normal tissues. Two miRNAs, miR-21 and miR-106b were found up-regulated in cancer tissues (P=0.0012 and P<0.001, respectively), while miR-375 down-regulated (P<0.001). Moreover, miR-21 and miR-106b levels were found significantly increased in poorly (G3)/moderately differentiated (G2) cancer tissues comparing with well differentiated (G1) and dysplasia (D) tissues (P<0.001, respectively). Their levels were also positively associated with lymph node metastasis (P<0.05) and TNM stages (P<0.01). However, miR-375 expression level was only found negatively associated with TNM stages. Our preliminary data suggest that three miRNAs, miR-21, miR-106b and miR- 375 might become novel tumor markers for LSCC diagnosis.
Export Options
About this article
Cite this article as:
Yu Xing, Wu Yibo, Liu Yang, Deng Hongxia, Shen Zhisen, Xiao Bingxiu and Guo Junming, miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma, Current Pharmaceutical Biotechnology 2014; 15 (5) . https://dx.doi.org/10.2174/1389201015666140519110616
DOI https://dx.doi.org/10.2174/1389201015666140519110616 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibition of Procarcinogen Activating Enzyme CYP1A2 Activity and Free Radical Formation by Caffeic Acid and its Amide Analogues
Drug Metabolism Letters FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes
Current Radiopharmaceuticals Targeting Telomerase for Cancer Therapy
Current Cancer Therapy Reviews HDAC as a Therapeutic Target for Treatment of Endometrial Cancers
Current Pharmaceutical Design Hepatocyte Growth Factor and Macrophage-stimulating Protein “Hinge” Analogs to Treat Pancreatic Cancer
Current Cancer Drug Targets Patent Selections:
Recent Patents on Medical Imaging Epithelial-Mesenchymal Transition: Implications in Cancer Progression and Metastasis
Current Pharmaceutical Biotechnology Polyisoprenylated Cysteinyl Amide Inhibitors: A Novel Approach to Controlling Cancers with Hyperactive Growth Signaling
Current Medicinal Chemistry Tapasin and Human Leukocyte Antigen Class I Dysregulation Correlates with Survival in Glioblastoma Multiforme
Anti-Cancer Agents in Medicinal Chemistry The Novel Functions of cGMP-Specific Phosphodiesterase 5 and its Inhibitors in Carcinoma Cells and Pulmonary/Cardiovascular Vessels
Current Topics in Medicinal Chemistry Potential Targets for Improving Radiosensitivity of Breast Tumor-Initiating Cells
Anti-Cancer Agents in Medicinal Chemistry Hypoxia Signaling and the Metastatic Phenotype
Current Molecular Medicine Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives
Current Pharmaceutical Design Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development
Current Cancer Drug Targets The Use of Specific Monoclonal Antibodies to Target Immunogenic Tumor Membrane Proteins in Patients with Recurrent Pancreatic and Colon Cancer
Current Drug Delivery Phytocompounds from the Medicinal and Dietary Plants: Multi-target Agents for Cervical Cancer Prevention and Therapy
Current Medicinal Chemistry Isovitexin Inhibits Stemness and Induces Apoptosis in Hepatocellular Carcinoma SK-Hep-1 Spheroids by Upregulating miR-34a Expression
Anti-Cancer Agents in Medicinal Chemistry Snake Venom Peptides and Low Mass Proteins: Molecular Tools and Therapeutic Agents
Current Medicinal Chemistry Targeting IL-17 and IL-23 in Immune Mediated Renal Disease
Current Medicinal Chemistry Viral Vectors for Gene-Directed Enzyme Prodrug Therapy
Current Gene Therapy